Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

2006 ◽  
Vol 1073-1074 ◽  
pp. 209-219 ◽  
Author(s):  
Sara González ◽  
Camila Scorticati ◽  
Moisés García-Arencibia ◽  
Rosario de Miguel ◽  
José A. Ramos ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Receptor Antagonist ◽  
Rat Model ◽  
Cb1 Receptor ◽  
Cannabinoid Cb1 Receptor ◽  
Cb1 Receptor Antagonist ◽  
Cannabinoid Cb1 Receptor Antagonist

scholarly journals Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

2009 ◽  
Vol 29 (1) ◽  
pp. 12-18 ◽  
Author(s):  
Frédérique Dol-Gleizes ◽  
Réjane Paumelle ◽  
Virgile Visentin ◽  
Anne-Marie Marés ◽  
Perrine Desitter ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Ldl Receptor ◽  
Cb1 Receptor ◽  
Cannabinoid Cb1 Receptor ◽  
Cb1 Receptor Antagonist ◽  
Deficient Mice ◽  
Cannabinoid Cb1 Receptor Antagonist

scholarly journals Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

2008 ◽  
Vol 33 (12) ◽  
pp. 2870-2877 ◽  
Author(s):  
Zuzana Justinova ◽  
Patrik Munzar ◽  
Leigh V Panlilio ◽  
Sevil Yasar ◽  
Godfrey H Redhi ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Cb1 Receptor ◽  
Cannabinoid Cb1 Receptor ◽  
Seeking Behavior ◽  
Cb1 Receptor Antagonist ◽  
Cannabinoid Cb1 Receptor Antagonist
Sign in / Sign up

Export Citation Format

Share Document